ESMO Congress 2026
October 23–27, 2026 · Madrid · 3101 items
adebrelimab
0 people · 0 posts
Floor
Stephen V Liu, MD@StephenVLiu LUNGevity Foundation@LUNGevity Stephen V Liu, MD@StephenVLiu clinicaltrials.gov A Phase I Study of HS-20093 in Combination With ZG006 With or Without Adebrelimab in Patients With ES-SCLC
clinicaltrials.gov A Single-Arm,Multicenter Phase, Phase II Clinical Trial of Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents
clinicaltrials.gov Adebrelimab Plus Famitinib as Adjuvant Therapy in Non-pCR NSCLC
clinicaltrials.gov Propranolol Hydrochloride Combined With Adebrelimab and Platinum-Based Chemotherapy in Small Cell Lung Cancer
Same topic adebrelimab · 11 peopleNo engagement yetCancer Cell Hitting KRAS G12D without the gut punch: Can immunotherapy make it last?
Cancer Cell Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer.
Cancer CellPick Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer
In the first clinical study of HRS-4642 combined with adebrelimab in previously treated patients with metastatic KRAS G12D-mutant pancreatic cancer, the chemotherapy-free regimen showed manageable safety and preliminary antitumor activity.
Why it matters: First clinical study of a chemotherapy-free combination in this patient population.
clinicaltrials.gov An Open, Multicenter Phase II Clinical Trial of SHR-A2009 Combined With Other Anti-tumor Therapies for Perioperative Treatment of Resectable Non-small Cell Lung Cancer.
Same topic adebrelimab · 11 peopleNo engagement yet